{
  "before_expansion": {
    "patterns": 9,
    "detection_rate_pct": 1.6
  },
  "after_expansion": {
    "total_patterns_defined": 3,
    "total_detected": 15,
    "detection_rate_pct": 1.4258555133079849,
    "by_type": {
      "cardiac_metabolic": 3,
      "inverse_indication": 3,
      "mechanism_mismatch": 9
    }
  },
  "success_criterion": ">5% detection rate",
  "result": "NOT MET",
  "detected_pairs": {
    "none": [],
    "cardiac_metabolic": [
      {
        "drug": "felodipine",
        "disease": "type 2 diabetes mellitus",
        "type": "cardiac_metabolic",
        "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
        "confidence": 0.5
      },
      {
        "drug": "amiloride",
        "disease": "type 2 diabetes mellitus",
        "type": "cardiac_metabolic",
        "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
        "confidence": 0.5
      },
      {
        "drug": "dobutamine",
        "disease": "type 2 diabetes mellitus",
        "type": "cardiac_metabolic",
        "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
        "confidence": 0.5
      }
    ],
    "inverse_indication": [
      {
        "drug": "simvastatin",
        "disease": "type 2 diabetes",
        "type": "inverse_indication",
        "reason": "Statins INCREASE T2D risk (HR 1.12-1.44) but prescribed for CV protection",
        "confidence": 0.9
      },
      {
        "drug": "hydrochlorothiazide",
        "disease": "type 2 diabetes mellitus",
        "type": "inverse_indication",
        "reason": "Thiazides cause hyperglycemia but prescribed for hypertension",
        "confidence": 0.9
      },
      {
        "drug": "quetiapine",
        "disease": "type 2 diabetes mellitus",
        "type": "inverse_indication",
        "reason": "Atypical antipsychotics CAUSE metabolic syndrome and T2D",
        "confidence": 0.9
      }
    ],
    "polypharmacy": [],
    "comorbidity": [],
    "mechanism_mismatch": [
      {
        "drug": "digitoxin",
        "disease": "type 2 diabetes",
        "type": "mechanism_mismatch",
        "reason": "Na+/K+-ATPase inhibition reduces GLUT4 translocation, worsening glucose",
        "confidence": 0.85
      },
      {
        "drug": "digoxin",
        "disease": "type 2 diabetes",
        "type": "mechanism_mismatch",
        "reason": "Na+/K+-ATPase inhibition reduces GLUT4 translocation, worsening glucose",
        "confidence": 0.85
      },
      {
        "drug": "pembrolizumab",
        "disease": "ulcerative colitis",
        "type": "mechanism_mismatch",
        "reason": "Checkpoint inhibitors CAUSE immune-related colitis",
        "confidence": 0.85
      },
      {
        "drug": "quetiapine",
        "disease": "parkinson disease",
        "type": "mechanism_mismatch",
        "reason": "Antipsychotics cause drug-induced parkinsonism via D2 blockade",
        "confidence": 0.85
      },
      {
        "drug": "pantoprazole",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "reason": "PPIs associated with 17% increased hypertension risk",
        "confidence": 0.85
      },
      {
        "drug": "gentamicin",
        "disease": "type 2 diabetes mellitus",
        "type": "mechanism_mismatch",
        "reason": "Aminoglycosides inhibit insulin release from beta cells",
        "confidence": 0.85
      },
      {
        "drug": "imipramine",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
        "confidence": 0.85
      },
      {
        "drug": "protriptyline",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
        "confidence": 0.85
      },
      {
        "drug": "amitriptyline",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
        "confidence": 0.85
      }
    ],
    "wrong_pathway": [],
    "cancer_target": []
  }
}